久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Industries

GSK probe shows tightened drug sector supervision

Xinhua | Updated: 2013-07-19 10:29

BEIJING - An ongoing probe into suspected economic violations by multinational drugmaker GlaxoSmithKline (GSK) employees is being seen as part of efforts to tighten supervision in the medical sector.

The Ministry of Public Security announced last week that some employees from GSK China are being investigated for suspected bribery and tax-related violations. Four senior executives from the company are being held by police over their alleged involvement.

The probe has shed light on instances of hidden bribery that have driven up medicine prices. However, the case is not the first of its kind to be uncovered in China.

In December last year, the US Securities and Exchange Commission (SEC) charged Eli Lilly and Company for its involvement in instances of alleged bribery that occurred in several countries, including China.

Four months before the Eli Lilly case, Pfizer's subsidiary in China was also found to have been involved in bribery.

The GSK suspects are believed to have several methods of concealment, such as channelling bribes through travel agencies.

It is believed that the exposure of the bribery represents just the tip of the iceberg.

An anonymous medical salesman from North China's Tianjin municipality said salesmen have had to come up with more creative ways to bribe doctors and convince them to raise the cost of their medicine.

"In most cases, the doctors don't extort money in such explicit terms, but it is certain that they will not order products from those who do not give them a 'good return'," he said.

The unfair market advantage that enterprises have gained by using bribery may make it harder for smaller companies to survive and develop. In addition, the costs of bribery are eventually transferred to patients.

According to suspect Liang Hong, a medication that costs only 30 yuan to produce could end up setting patients back 300 yuan due to bribery.

Bribery can also affect patients' health, as bribes may influence doctors' decisions regarding what medication to prescribe.

A commerce official said Wednesday that the GSK probe is part of efforts to improve China's business climate and create equal competition opportunities for domestic and overseas investors.

The official said China firmly opposes any form of commercial bribery, and all companies, Chinese and foreign alike, will be subject to legal sanctions and assume legal responsibility if they break Chinese law.

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 高清精品一区二区三区一区 | 真实国产乱人伦在线视频播放 | 97在线视频免费观看费观看 | 欧美综合另类 | 日韩特级毛片 | 久久久国产免费影院 | 久久香蕉国产线看观看精品yw | 精品午夜一区二区三区在线观看 | 成人三级视频在线观看 | 在线看国产 | 国产高清免费观看 | 欧美成人伊人十综合色 | 久久久久亚洲精品一区二区三区 | 久久久精品免费热线观看 | 免费看a级 | 国产亚洲精品久久综合影院 | 国产一级做a爰片久久毛片99 | 免费人成网站在线播放 | 久久久久久久免费 | 国产午夜精品免费一二区 | 欧美精品久久天天躁 | 国产日产精品_国产精品毛片 | 中文字幕乱 | 久久只有这才是精品99 | 成年人午夜免费视频 | 亚洲精品15p | 性欧美精品孕妇 | 亚洲一区免费在线 | 成人网18免费网站在线 | 国产不卡精品一区二区三区 | 日韩在线视频中文字幕 | 国产成人禁片免费观看视频 | 亚州男人天堂 | 女人张开腿男人猛桶视频 | 国产一级成人毛片 | 国产在线观看高清不卡 | 手机在线观看精品国产片 | 97精品国产综合久久久久久欧美 | 国内精品久久久久久久星辰影视 | 夜色毛片永久免费 | 国产一区二区在线播放 |